Tavexia Lifecare board approves 60% Meyonex stake
Tavexia Lifecare’s board approved the acquisition of a 60% controlling stake in Meyonex Pharmaceuticals. The deal is valued at 671.9 million rupees.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Reuters reports that Tavexia Lifecare’s board has approved the purchase of a 60% stake in Meyonex Pharmaceuticals, giving the company a controlling interest in the pharmaceutical business.
Tavexia Lifecare Ltd said the acquisition is valued at 671.9 million rupees.
why it matters
The transaction would change Meyonex Pharmaceuticals’ ownership structure and give Tavexia Lifecare control through the acquired 60% stake at the stated valuation.
sources
- Tavexia Lifecare Says Board Approves Acquisition Of Controlling Stake In Meyonex Pharma — Reuters, 12 October 2026 at 13:18 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗